MMP7 and cancer: We suggest that our findings reported here are most applicable to PCa tumors with a luminal PCS2 subtype, and perhaps a more aggressive luminal PCS1 subtype, and less relevant for cancers that already produce significant amounts of MMP-7 that can readily cleave the PSPN Complex components.